ino 2628-cz has been researched along with nicorandil in 1 studies
Studies (ino 2628-cz) | Trials (ino 2628-cz) | Recent Studies (post-2010) (ino 2628-cz) | Studies (nicorandil) | Trials (nicorandil) | Recent Studies (post-2010) (nicorandil) |
---|---|---|---|---|---|
8 | 0 | 0 | 1,487 | 207 | 428 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akahane, K; Chiba, S; Furukawa, Y; Ogiwara, Y | 1 |
1 other study(ies) available for ino 2628-cz and nicorandil
Article | Year |
---|---|
K+ channel blocking and anti-muscarinic effects of a novel piperazine derivative, INO 2628, on the isolated dog atrium.
Topics: Adenosine; Animals; Atrial Function; Depression, Chemical; Dogs; Dose-Response Relationship, Drug; Guanidines; Heart Atria; Myocardial Contraction; Niacinamide; Nicardipine; Nicorandil; Pinacidil; Piperazines; Potassium Channels; Time Factors | 1991 |